issue contents
November 2020 issue
![Highlighted illustration](/e/issues/2020/11/00/graphics/coverill.gif)
Cover illustration: In the search for new compounds with potential pharmaceutical applications, the new nitrobenzamide derivative N-{3-[(4-methoxyphenyl)carbamoyl]phenyl}-3-nitrobenzamide was synthesized and thoroughly characterized. The structure is held by a network of strong N-HO and C-H
O hydrogen bonds. Hirshfeld surface analysis indicates these interactions, along with H
H and H
C/C
H contacts, contribute close to 90% to the crystal packing. The coupling of the title compound and of the well-known anticoagulant Apixaban with the human coagulation factor hfXa as the receptor protein was evaluated through molecular docking studies, indicating the compound has inhibitory activity. See: Moreno-Fuquen, Hurtado-Angulo, Arango-Daraviña, Bain & Kennedy [Acta Cryst. (2020). E76, 1762-1767].
research communications
![cross.png](/logos/buttonlogos/cross.png)
![cross.png](/logos/buttonlogos/cross.png)
![cross.png](/logos/buttonlogos/cross.png)
![cross.png](/logos/buttonlogos/cross.png)
![cross.png](/logos/buttonlogos/cross.png)
![cross.png](/logos/buttonlogos/cross.png)
![cross.png](/logos/buttonlogos/cross.png)
![cross.png](/logos/buttonlogos/cross.png)
![cross.png](/logos/buttonlogos/cross.png)
![cross.png](/logos/buttonlogos/cross.png)
![cross.png](/logos/buttonlogos/cross.png)
![cross.png](/logos/buttonlogos/cross.png)
![cross.png](/logos/buttonlogos/cross.png)
![cross.png](/logos/buttonlogos/cross.png)
![cross.png](/logos/buttonlogos/cross.png)
![cross.png](/logos/buttonlogos/cross.png)
![cross.png](/logos/buttonlogos/cross.png)
![cross.png](/logos/buttonlogos/cross.png)
![\overline{1}](/e/issues/2020/11/00/is5553/teximages/is5553fi1.gif)
![cross.png](/logos/buttonlogos/cross.png)
![cross.png](/logos/buttonlogos/cross.png)
![cross.png](/logos/buttonlogos/cross.png)
![cross.png](/logos/buttonlogos/cross.png)
![cross.png](/logos/buttonlogos/cross.png)
![cross.png](/logos/buttonlogos/cross.png)
![R_{4}^{4}](/e/issues/2020/11/00/dj2015/teximages/dj2015fi1.gif)
![cross.png](/logos/buttonlogos/cross.png)
![cross.png](/logos/buttonlogos/cross.png)
![cross.png](/logos/buttonlogos/cross.png)
![cross.png](/logos/buttonlogos/cross.png)
![cross.png](/logos/buttonlogos/cross.png)
![cross.png](/logos/buttonlogos/cross.png)
![cross.png](/logos/buttonlogos/cross.png)
![cross.png](/logos/buttonlogos/cross.png)
![cross.png](/logos/buttonlogos/cross.png)
![cross.png](/logos/buttonlogos/cross.png)
![\overline{1}](/e/issues/2020/11/00/jq2001/teximages/jq2001fi1.gif)
![cross.png](/logos/buttonlogos/cross.png)
![cross.png](/logos/buttonlogos/cross.png)
![cross.png](/logos/buttonlogos/cross.png)
![cross.png](/logos/buttonlogos/cross.png)